Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread worldwide since December …

Context.—Acute pulmonary injury may occur as a result of myriad direct or indirect
pulmonary insults, often resulting in hypoxemic respiratory failure and clinical acute …

With an increasing number of therapeutic drugs, the list of drugs that is responsible for
severe pulmonary disease also grows. Many drugs have been associated with pulmonary …

Fifteen monoclonal antibodies (mAbs) are currently registered and approved for the
treatment of a range of different cancers. These mAbs are specific for a limited number of …

Organizing pneumonia (OP) is a pathological pattern defined by the characteristic presence
of buds of granulation tissue within the lumen of distal pulmonary airspaces consisting of …

Organizing pneumonia (formerly named bronchiolitis obliterans with organizing pneumonia
or BOOP) is a clinical, radiological and histological entity that is classified as an Interstitial …

Organizing pneumonia (OP), characterized histopathologically by patchy filling of alveoli
and bronchioles by loose plugs of connective tissue, may be seen in a variety of conditions …

More than 100 drugs are used to treat the many different cancers. They can be divided into
agents with relatively broad, non-targeted specificity and targeted drugs developed on the …

Bronchiolitis obliterans (BO) is a major cause of chronic airway dysfunction after toxic
chemical inhalation. The pathophysiology of BO is not well understood, but epithelial cell …

Interstitial lung diseases (ILDs), also called diffuse parenchymal lung diseases, are a large
heterogenous group of non-infectious, non-neoplastic disorders characterized by varied …